title: [The outlook for the management of endometrial hyperplasia. A preliminary report].
authors.forename: M T
authors.initials: MT
authors.lastname: Martínez-Meza
authors.forename: I
authors.initials: I
authors.lastname: Sojo-Aranda
authors.forename: H
authors.initials: H
authors.lastname: Santiago-Payán
authors.forename: M
authors.initials: M
authors.lastname: González-Diddi
authors.forename: V
authors.initials: V
authors.lastname: Cortés-Gallegos
mesh_terms: D000328:Adult; D004341:Drug Evaluation; D004714:Endometrial Hyperplasia / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009640:Norethindrone / Q000009:adverse effects / Q000627:therapeutic use; D014592:Uterine Hemorrhage / Q000188:drug therapy / Q000209:etiology
chemical_list: D009640:Norethindrone
vernacular_title: Perspectivas de manejo en la hiperplasia endometrial. Informe preliminar.